SAN FRANCISCO, Feb. 27, 2014 /PRNewswire/ -- Medizone
International, Inc. (MZEI:OB MZEI:QB) announces the addition of
David Esposito to the Board of
Directors. Medizone makes this move in anticipation of full
US regulatory approval of the Company's AsepticSure® hospital
disinfection system.
"As Medizone International continues to move forward with our
growth strategy, it is important that we continue to attract
talented commercial leaders to help the organization reach its
potential in establishing the AsepticSure system as the new gold
standard for disinfection across a wide range of commercial
applications," commented Edwin
Marshall, CEO of Medizone International. "As we
prepare for the global commercialization of the AsepticSure system,
we are pleased to announce that David
Esposito has joined our Board of Directors to help support
our commercial strategy and business development initiatives."
David has tremendous commercial experience as a senior executive
in both the pharmaceutical and medical diagnostic markets.
Over a 15-year career with Merck & Co., David played key roles
in sales, marketing, and commercial strategy. David, as the
former President and General Manager of Phadia US Inc., a leading
specialty diagnostics company, helped drive significant growth in
the US market and was a key member of the Phadia Leadership Team
that successfully sold the business to Thermo Fisher Scientific for
$3.5 Billion USD in 2011. Post
the acquisition, David led the US Commercial Operations for a
division of Thermo Fisher Scientific. Prior to his commercial
success in the healthcare marketplace, David graduated from the
United States Military Academy at West
Point with a BS in Civil Engineering. As an Infantry
Platoon Leader with the 101st Airborne Division, David
was awarded a Bronze Star during the Persian Gulf War. David also
holds a Master of Business Administration from Syracuse University.
"We are very excited to have David
Esposito join the Board of Directors at Medizone
International," continued Mr. Marshall. "We are at a critical
phase in our growth plan and we look forward to the contributions
David will make in helping to support our strategy and business
development initiatives."
David Esposito commented on
joining the Board of Directors, "I consider it a great privilege to
join such a group of talented leaders on the Medizone International
team. The AsepticSure system has the potential to effectively
address a significant unmet need in the market for more effective
disinfection systems for hospitals, long term care facilities, and
a number of applications beyond the healthcare marketplace. I
look forward to being a very active member of the Board of
Directors to support the team reaching our full commercial
potential."
This Press Release may contain certain forward looking
statements that could involve substantial risks and uncertainties,
including, but not limited to, the results of ongoing clinical
studies, economic conditions, product and technology development,
production efficiencies, product demand, competitive products,
competitive environment, successful testing and government
regulatory issues. Additional risks are identified in the company's
filings made with the Securities and Exchange Commission.
For press information on Medizone International, please
contact:
John Pentony, Investor Relations,
Medizone International, Inc.
T: (415) 331-0202
E: j.pentony@medizoneint.com
Gary Hanauer, Media Contact
Medizone International, Inc.
T: (510) 686-1238
E: GarHan@aol.com
For more information, visit:
http://www.medizoneint.com
Email: operations@medizoneint.com
SOURCE Medizone International, Inc.